CIK 0001739104 · Large accelerated filer
Elanco Animal Health Inc
Sign in to watch- Ticker
- ELAN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 825497352
- Phone
- 877-352-6261
- Business address
- 450 ELANCO CIRCLE, INDIANAPOLIS, IN, 46221
- Open-market buys, last 90 days
- $1,030,193
- in 2 filings
- Open-market sales, last 90 days
- $100,050
- in 1 filing, $100K under 10b5-1 plans
Net +$930,143. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-01 | Bettington Timothy J SEE REMARKS | Grant or award | +46,322 | 156,584 | ||
| 2026-03-01 | Bettington Timothy J SEE REMARKS | Shares withheld for taxes | −18,098 | $26.40 | $478K | 138,486 |
| 2026-03-01 | Bettington Timothy J SEE REMARKS | Grant or award | +9,470 | 147,956 | ||
| 2026-03-01 | Bettington Timothy J SEE REMARKS | Grant or award · Employee Stock Option (right to buy) | +19,350 | 19,350 | ||
| 2026-03-01 | Meer James M CHIEF ACCOUNTING OFFICER | Grant or award | +9,596 | 67,699 | ||
| 2026-03-01 | Meer James M CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −4,787 | $26.40 | $126K | 62,912 |
| 2026-03-01 | Meer James M CHIEF ACCOUNTING OFFICER | Grant or award | +5,209 | 68,121 | ||
| 2026-03-01 | Kinard David S SEE REMARKS | Grant or award | +33,087 | 223,604 | ||
| 2026-03-01 | Kinard David S SEE REMARKS | Shares withheld for taxes | −15,377 | $26.40 | $406K | 208,227 |
| 2026-03-01 | Kinard David S SEE REMARKS | Grant or award | +9,470 | 217,697 | ||
| 2026-03-01 | Kinard David S SEE REMARKS | Grant or award · Employee Stock Option (right to buy) | +19,350 | 19,350 | ||
| 2026-03-01 | Cabral Ramiro Martin SEE REMARKS | Grant or award | +60,053 | 299,682 | ||
| 2026-03-01 | Cabral Ramiro Martin SEE REMARKS | Shares withheld for taxes | −30,150 | $26.40 | $796K | 269,532 |
| 2026-03-01 | Cabral Ramiro Martin SEE REMARKS | Grant or award | +20,834 | 290,366 | ||
| 2026-03-01 | Cabral Ramiro Martin SEE REMARKS | Grant or award · Employee Stock Option (right to buy) | +42,570 | 42,570 | ||
| 2026-03-01 | VanHimbergen Robert M EVP and CFO | Grant or award | +23,675 | 148,652 | ||
| 2026-03-01 | VanHimbergen Robert M EVP and CFO | Grant or award · Employee Stock Option (right to buy) | +48,375 | 48,375 | ||
| 2026-03-01 | Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR | Grant or award | +397,041 | 2,200,459 | ||
| 2026-03-01 | Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −229,982 | $26.40 | $6.1M | 1,970,477 |
| 2026-03-01 | Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR | Grant or award | +119,319 | 2,089,796 |
Page 7 of 20 · 392 trades